Bioluminescence imaging of Hepatitis C virus NS3/4A serine protease activity in cells and living animals

被引:23
作者
Wang, Licui [1 ]
Fu, Qiuxia [1 ]
Dong, Yafeng [1 ]
Zhou, Yong [1 ]
Jia, Shuaizheng [1 ]
Du, Juan [1 ]
Zhao, Fang [1 ]
Wang, Yingli [1 ]
Wang, Xiaohui [1 ]
Peng, Jianchun [1 ]
Yang, Shuhua [1 ]
Zhan, Linsheng [1 ]
机构
[1] Beijing Inst Transfus Med, Lab Blood Borne Virus, Beijing 100850, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
NS3/4A protease; Split firefly luciferase complementation strategy; In vivo imaging; RNA REPLICATION; IN-VIVO; INFECTION; CULTURE; ASSAY; INTERFERENCE; REPLICON; VIREMIA; LINES;
D O I
10.1016/j.antiviral.2010.04.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The lack of robust small animal models has been an obstacle to the screening of Hepatitis C virus (HCV) NS3/4A protease inhibitors in vivo. Here, we described a reporter assay system for in vivo noninvasive imaging of NS3/4A serine protease activity using split firefly luciferase complementation strategy. The reporter construct ANIuc(NS5A/B)BCluc constitutes the split N- and C-terminal fragments of luciferase, fused to interacting peptides, pepA and pepB, respectively, with an intervening HCV NS3/4A cleavage motif of NSSA/B. we proved that the reporter molecule could be proteolytically cleaved by NS3/4A at the NS5A/B motif in cells and living animals. Association of pepA and pepB brought inactive fragments of luciferase into close proximity, thereby restoring bioluminescence activity. The increase in luciferase activity was proportional to the dose of active NS3/4A protease. The ANIuc(NS5A/B)BCluc reporter also could be used to detect the activity of NS3/4A-specific shRNA and IFN-alpha. Therefore, the reporter assay system using split firefly luciferase complementation strategy should prove useful for evaluating NS3/4A protease activity in cells and living animals. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 39 条
[1]   3 DIFFERENT PATTERNS OF HEPATITIS-C VIRUS-INFECTION IN CHIMPANZEES [J].
ABE, K ;
INCHAUSPE, G ;
SHIKATA, T ;
PRINCE, AM .
HEPATOLOGY, 1992, 15 (04) :690-695
[2]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[3]   A novel high throughput screening assay for HCVNS3 serine protease inhibitors [J].
Berdichevsky, Y ;
Zemel, R ;
Bachmatov, L ;
Abramovich, A ;
Koren, R ;
Sathiyamoorthy, P ;
Golan-Goldhirsh, A ;
Tur-Kaspa, R ;
Benhar, I .
JOURNAL OF VIROLOGICAL METHODS, 2003, 107 (02) :245-255
[4]   Engineered luciferases for molecular sensing in living cells [J].
Binkowski, Brock ;
Fan, Frank ;
Wood, Keith .
CURRENT OPINION IN BIOTECHNOLOGY, 2009, 20 (01) :14-18
[5]   Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication [J].
Blight, KJ ;
McKeating, JA ;
Rice, CM .
JOURNAL OF VIROLOGY, 2002, 76 (24) :13001-13014
[6]   Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture [J].
Blight, KJ ;
McKeating, JA ;
Marcotrigiano, J ;
Rice, CM .
JOURNAL OF VIROLOGY, 2003, 77 (05) :3181-3190
[7]   Experimental Models for Hepatitis C Viral Infection [J].
Boonstra, Andre ;
van der Laan, Luc J. W. ;
Vanwolleghem, Thomas ;
Janssen, Harry L. A. .
HEPATOLOGY, 2009, 50 (05) :1646-1655
[8]   Development of cell-based assays for in vitro characterization of hepatitis C virus NS3/4A protease inhibitors [J].
Chung, V ;
Carroll, AR ;
Gray, NM ;
Parry, NR ;
Thommes, PA ;
Viner, KC ;
D'Souza, EA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) :1381-1390
[9]   Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection [J].
ConryCantilena, C ;
VanRaden, M ;
Gibble, J ;
Melpolder, J ;
Shakil, AO ;
Viladomiu, L ;
Cheung, L ;
DiBisceglie, A ;
Hoofnagle, J ;
Shih, JW ;
Kaslow, R ;
Ness, P ;
Alter, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1691-1696
[10]   Noninvasive imaging of apoptosis and its application in cancer therapeutics [J].
Coppola, Julia M. ;
Ross, Brian D. ;
Rehemtulla, Alnawaz .
CLINICAL CANCER RESEARCH, 2008, 14 (08) :2492-2501